Life Healthcare Group Holdings Limited

JSE:LHC Stok Raporu

Piyasa değeri: R23.2b

Life Healthcare Group Holdings Yönetim

Yönetim kriter kontrolleri 4/4

Life Healthcare Group Holdings CEO'su Peter Wharton-Hood, Sep2020 tarihinde atandı, in görev süresi 4.17 yıldır. in toplam yıllık tazminatı ZAR 18.91M olup, şirket hissesi ve opsiyonları dahil olmak üzere 46.4% maaş ve 53.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.18% ine doğrudan sahiptir ve bu hisseler ZAR 42.31M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 4.6 yıldır.

Anahtar bilgiler

Peter Wharton-Hood

İcra Kurulu Başkanı

R18.9m

Toplam tazminat

CEO maaş yüzdesi46.4%
CEO görev süresi4.2yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresi4.2yrs
Yönetim Kurulu ortalama görev süresi4.6yrs

Son yönetim güncellemeleri

Recent updates

Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17

Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends

We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings

Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued

Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?

Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

May 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 44%?

Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

Apr 28
Be Wary Of Life Healthcare Group Holdings (JSE:LHC) And Its Returns On Capital

An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

Feb 08
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 30% Undervalued

There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

Jan 25
There Are Reasons To Feel Uneasy About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital

With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Jan 08
With Life Healthcare Group Holdings Limited (JSE:LHC) It Looks Like You'll Get What You Pay For

Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Nov 28
Does Life Healthcare Group Holdings (JSE:LHC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Oct 19
Are Investors Undervaluing Life Healthcare Group Holdings Limited (JSE:LHC) By 24%?

Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

Aug 16
Life Healthcare Group Holdings (JSE:LHC) Is Reinvesting At Lower Rates Of Return

We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Jul 20
We Think Life Healthcare Group Holdings (JSE:LHC) Is Taking Some Risk With Its Debt

Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

May 14
Capital Allocation Trends At Life Healthcare Group Holdings (JSE:LHC) Aren't Ideal

How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

Mar 21
How Many Life Healthcare Group Holdings Limited (JSE:LHC) Shares Did Insiders Buy, In The Last Year?

CEO Tazminat Analizi

Peter Wharton-Hood'un ücretlendirmesi Life Healthcare Group Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2024n/an/a

R1b

Dec 31 2023n/an/a

R1b

Sep 30 2023R19mR9m

R1b

Mar 31 2023n/an/a

R1b

Dec 31 2022n/an/a

R1b

Sep 30 2022R18mR8m

R1b

Mar 31 2022n/an/a

R2b

Dec 31 2021n/an/a

R2b

Sep 30 2021R18mR8m

R2b

Mar 31 2021n/an/a

R629m

Dec 31 2020n/an/a

R668m

Sep 30 2020R8mR641k

R706m

Tazminat ve Piyasa: Peter 'ın toplam tazminatı ($USD 1.07M ) ZA pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.36M ).

Tazminat ve Kazançlar: Peter 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Peter Wharton-Hood (58 yo)

4.2yrs

Görev süresi

R18,907,000

Tazminat

Mr. Peter G. Wharton-Hood, (BCom (Hons) (Wits), CA(SA), AMP (Harvard)), serves as the Group Chief Executive Officer at Life Healthcare Group Holdings since September 1, 2020 and also serves as its Executiv...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Peter Wharton-Hood
Group CEO & Executive Director4.2yrsR18.91m0.18%
ZAR 42.3m
Pieter van der Westhuizen
Group CFO & Executive Director11.4yrsR13.81m0.096%
ZAR 22.4m
Adam Pyle
Chief Strategy & Growth Officer and Executive Head of Investor Relationsno dataR10.37mVeri yok
Craig Koekemoer
Chief Operations Officerless than a yearVeri yokVeri yok
Avanthi Parboosing
Chief People Officer3.7yrsVeri yokVeri yok
Megan Naidoo
Chief Financial Officer of South Africa4.9yrsVeri yokVeri yok
Joshila Ranchhod
Group Company Secretary3.7yrsVeri yokVeri yok
Guy Blomfield
Non-Executive Director of Life UK6.4yrsR16.34mVeri yok
Nick Burley
Non-Executive Director of Life UKno dataVeri yokVeri yok

4.2yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: LHC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Peter Wharton-Hood
Group CEO & Executive Directorno dataR18.91m0.18%
ZAR 42.3m
Pieter van der Westhuizen
Group CFO & Executive Director11.4yrsR13.81m0.096%
ZAR 22.4m
Lars Holmqvist
Independent Non-Executive Director2.3yrsR2.84mVeri yok
Audrey Mothupi
Independent Non-Executive Director7.3yrsR1.03mVeri yok
Mahlape Sello
Lead Independent Non-Executive Director7.3yrsR1.10mVeri yok
Joel Netshitenzhe
Independent Non-Executive Director14yrsR852.00kVeri yok
Caroline Henry
Independent Non-Executive Director3.2yrsR1.19mVeri yok
Marian Jacobs
Independent Non-Executive Director10.8yrsR896.00kVeri yok
Victor Litlhakanyane
Independent Non-Executive Chairman4.6yrsR2.10m0.00069%
ZAR 160.4k
Fulvio Tonelli
Independent Non-Executive Director1.6yrsR555.00kVeri yok
Tebogo Moeketsi
Independent Non-Executive Director1.8yrsR627.00kVeri yok
Jeanne Bolger
Independent Non-Executive Director2.3yrsR2.74mVeri yok

4.6yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: LHC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.6 yıldır).